
Nexmoir 250mg Injection
Marketer
H & I Critical Care
Salt Composition
Meropenem (250mg)
Overview Nexmoir 250mg Injection
InfectiCare 250mg injection combats severe bacterial infections affecting the skin, lungs, gastrointestinal tract, urinary system, bloodstream, and central nervous system (including meningitis). Its mechanism involves bacterial eradication. Ineffective against viral infections, InfectiCare 250mg is primarily administered intravenously (IV) to critically ill hospitalized patients under medical supervision, either by infusion or direct injection. Dosage is tailored to infection severity, location, and type. Complete the prescribed course, even with symptom improvement; premature cessation may lead to relapse or exacerbation. Potential side effects, such as headache, nausea, gastrointestinal upset (constipation or diarrhea), anemia, vomiting, and rash, are typically transient. Persistent or bothersome side effects warrant medical consultation. Prior to commencing treatment, disclose any pre-existing conditions, including epilepsy, hepatic or renal impairment, or antibiotic allergies. Regular blood tests may be recommended to monitor hematological parameters and renal function. Generally considered safe for pregnant and breastfeeding individuals under medical guidance.
Uses of Nexmoir 250mg Injection
Life-threatening bacterial infestations
Major Benefits of Nexmoir 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Nexmoir 250mg Injection:
- Rash
- Headache
- Vomiting
- Nausea
- Itching
- Diarrhea
- Injection site inflammation
- Anemia (low number of red blood cells)
- Sepsis
- Constipation
- Apnea (absence of breathing)
- Shock
How to use Nexmoir 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Nexmoir 250mg Injection works:
Bactrim 250mg injection is a bacterial agent. Its mechanism of action involves disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's protective barrier and causing cell death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Nexmoir 250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Nexmoir, 250mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Nexmoir 250mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates insignificant danger to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Nexmoir 250mg Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Nexmoir 250mg Injection judiciously. Dosage modification of Nexmoir 250mg Injection may be necessary. A physician's advice is recommended.
LiverSAFE IF PRESCRIBED
The 250mg Nexmoir injection presents no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Nexmoir 250mg Injection :
Omit a Nexmoir 250mg Injection dose? Seek medical advice.
Facts to Know About Nexmoir 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Carbapenem-based antibiotic |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Carbapenems: Cell Wall Inhibitors |
